STERIS’s (STE) “Overweight” Rating Reiterated at Piper Sandler

Дата публикации: 10-08-2026 05:48:47

Piper Sandler reiterated their overweight rating on shares of STERIS (NYSE:STE – Free Report) in a research note released on Friday,Benzinga reports. They currently have a $275.00 price objective on the medical equipment provider’s stock, up from their prior price objective of $270.00. A number of other research firms also recently commented on STE. KeyCorp […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Sotera Health’s (SHC) Overweight Rating Reiterated at Piper Sandler	0	9.05	10-08-2026
2	Teleflex’s (TFX) Overweight Rating Reiterated at Piper Sandler	0	10.31	10-08-2026
3	Definium Therapeutics’ (DFTX) “Overweight” Rating Reiterated at Piper Sandler	0	8.75	10-08-2026
4	Shoulder Innovations’ (SI) Overweight Rating Reiterated at Piper Sandler	0	8.45	10-08-2026
5	Somnigroup International’s (SGI) “Overweight” Rating Reiterated at Piper Sandler	0	9.05	10-08-2026
6	ICU Medical (NASDAQ:ICUI) Price Target Raised to $195.00	0	11.84	10-08-2026
7	Piper Sandler Cuts ResMed (NYSE:RMD) Price Target to $225.00	0	10.45	10-08-2026
8	Doximity’s (DOCS) “Overweight” Rating Reiterated at Piper Sandler	0	9.98	10-08-2026
9	Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $175.00	0	12.26	10-08-2026
10	Xperi’s (XPER) “Buy” Rating Reiterated at BWS Financial	0	7.11	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.98. Источник: www.americanbankingnews.com.